RAG-12

N/A

Report date: 2024/11/27 16:54:59
NME

Base Information

Drug NameRAG-12
Drug Alias NameRAG-12
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionPlasma protease C1 inhibitor gene transference
TargetsPlasma protease C1 inhibitor
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRactigen Therapeutics (Nantong) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRactigen Therapeutics (Nantong) Co Ltd
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A